Entity Details

Primary name DMXL2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ8TDJ6
EntryNameDMXL2_HUMAN
FullNameDmX-like protein 2
TaxID9606
Evidenceevidence at protein level
Length3036
SequenceStatuscomplete
DateCreated2006-03-07
DateModified2021-06-02

Ontological Relatives

GenesDMXL2

GO terms

Show/Hide Table
GOName
GO:0005615 extracellular space
GO:0007035 vacuolar acidification
GO:0008021 synaptic vesicle
GO:0030672 synaptic vesicle membrane
GO:0031267 small GTPase binding
GO:0043291 RAVE complex
GO:0098992 neuronal dense core vesicle

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasmic vesicle

Domains

Show/Hide Table
DomainNameCategoryType
IPR001680 WD40 repeatRepeatRepeat
IPR015943 WD40/YVTN repeat-like-containing domain superfamilyFamilyHomologous superfamily
IPR022033 RAVE complex protein Rav1 C-terminalDomainDomain
IPR036322 WD40-repeat-containing domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
618663 OMIMDevelopmental and epileptic encephalopathy 81 (DEE81)A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE81 is an autosomal recessive form characterized by onset soon after birth, little developmental progress with no eye contact and no motor or cognitive development. Other features may include facial dysmorphism, such as hypotonic facies and epicanthal folds, as well as sensorineural hearing loss and peripheral neuropathy. The disease is caused by variants affecting the gene represented in this entry.
617605 OMIMDeafness, autosomal dominant, 71 (DFNA71)A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA71 is characterized by bilateral mild to moderate hearing loss before age 20 years, which gradually progresses to severe to profound hearing loss. The disease is caused by variants affecting the gene represented in this entry.
616113 OMIMPolyendocrine-polyneuropathy syndrome (PEPNS)A progressive endocrine and neurodevelopmental disorder manifesting early in childhood with growth retardation and recurrent episodes of profound asymptomatic hypoglycemia. PEPNS is characterized by central hypothyroidism, hypogonadotropic hypogonadism, incomplete puberty, progressive non-autoimmune insulin-dependent diabetes mellitus, peripheral demyelinating sensorimotor polyneuropathy, and cerebellar and pyramidal signs. The disease is caused by variants affecting the gene represented in this entry.